FREMONT, Calif., June 14, 2016 /PRNewswire/ -- ValGenesis, a leading provider of paperless validation lifecycle management software solutions, today announced the launch of its successful relationship with the World's Leading Fortune 500 Medical Technology organization. The leading device company enhances Orthopedics, Medical and Surgical arenas, providing innovative products and services that help patients lead healthier and improved lives.
The global leading manufacturer invested significant time and resources to standardize their validation processes globally, across all divisions and sites. To facilitate and streamline the standardization, the manufacturer augmented the process with an electronic system. Upon thorough evaluation of in-house tools, as well as other newer solutions, the company selected ValGenesis as the proper tool for their organization.
Accessing ValGenesis VLMS through the enterprise-ready validated ValGenesis Cloud, allows companies to implement and deploy the system rapidly with less investment and in a shorter period of time. The ValGenesis Cloud solution is hosted in an SSAE 16 SOC 2 Type 2-certified data center, the most advanced infrastructure available. Through an independent evaluation, the hosted private ValGenesis Cloud has received Service Organization Control 2 (SOC 2) Type 1 Certification under AT Section 101.
After the successful implementation of the ValGenesis solution and upon using the ValGenesis Validated Cloud platform at one of their major manufacturing sites; the medical technology company rolled out a plan to extend the use of the solution to all the company's sites globally. "These are exciting frontiers for ValGenesis, as more and more global Life science organizations are selecting and implementing ValGenesis to help standardize and manage the critical regulatory process of validation across business units and sites globally," commented Narayan Raj, Vice President of ValGenesis Inc. "ValGenesis is clearly the right tool for becoming a de-facto standard for global life science companies that wish to perform and manage validation activities more efficiently. Not only does ValGenesis allow Life science companies to manage their validation processes electronically; it reduces the validation cycle time, enables standardization, and enforces consistency and compliance in the corporate validation process."
ValGenesis, Inc. is the creator of an innovative software platform serving as the foundation for managing compliance-based validation activities in Life Sciences companies. ValGenesis, Inc. provides the first enterprise application to manage the corporate validation lifecycle process. As the only system for managing validation execution and approval 100% electronically, ValGenesis was selected by an industry peer review committee to receive the Parenteral Drug Association (PDA) New Innovative Technology Award. The solution is fully compliant with U.S. FDA 21 CFR Part 11 and Annex 11 requirements. For more information, visit www.valgenesis.com.
To view the original version on PR Newswire, visit:http://www.prnewswire.com/news-releases/worlds-leading-medical-technology-company-implements-valgenesis-vlms-to-augment-revised-validation-management-process-globally-300283580.html
SOURCE ValGenesis Inc.